Radiolucent cholesterol gallstones can be dissolved rapidly by methyl terc-buryl ether (MTBE) introduced directly into the gallbladder. Percutaneous transhepatic catheter placement is a well established interventional radiology procedure and is the preferred route for MTBE administration. A small number of patients have been treated using nasobiliary placement of a gallbladder catheter. Rapid stirring automatic pump systems allow dissolutio n of most cholesterol stones, but some may require extracorporeal shock wave litho tripsy to achieve complete dissolution and aspiration of debris. Large hore percutaneous fragmentation and extraction methods require general anesthesia but are applicable to pigment stones. Can J Gastroenterol l 990;4(9):624-62 7 La dissolution percutanee des lithiases biliaires par instillation de methyl tert-butyl ether RESUME: Les lithiases cholesteroliques radiotransparentes sont aisement dissoutes par instillation directe de methyl terr-butyl ether (MTBE) clans la vesicule biliaire. La mise en place d'un catheter transhepatique percutane est une intervention radiologique bien etablie el represente la voie preferee pour ['administration du MTBE. Un petit nombre de patients one ete traites par drainage nasobiliaire. Les pompes rotatives rapides viennent a bo ut de la plupart des calculs cholesteroliques mais pour parvenir a la dissolution et a ['aspiration completes des debris, ii est parfois necessaire de reco urir a une lithotritie extracorporelle par ondes de choc (LEOC). Une anesthesie generale est necessaire a la fragmentation et a !'extraction des gros calculs, methodes qui s'appliquent egalement aux calculs pigmencaires.
0 ADl\)LUCENT Cl IOLE5T1:ROL GAU· ~tones can be rapidly JissolvcJ m vitro by methyl cert-butyl ether (MTBE) (1 ). This rapidly effernve cholesterol solvent is an alkyl ctherliq· uid at body temperature (boiling point 55°C) a nd will dissolve even large c h o lesterol stones (4 to 6 cm m <liameter) within hours (2) . Anim~ and human stu<l ies have demonstrated little toxicity when MTBE 1s retained in the gallhladder (2, 3 ) . Continuous m, fusion into the duoJenum may prcxluce duodenitis and extensive systemic a~. sorp ti o n can 10Juce intravascular hemolysis. Both of these side effects can easily be avoiJ cd by retrieval of most of the administered MTBE. This solvent remains invest igational fo r human 1l\C in the United States.
PERCUTANEOUS TRANSHEPATIC CATHETER PLACEMENT
Introduction of a SF ( 1.7 mm) pigtail catheter through the hepatic-gallblaJ. der attachmen t into the gallbladdercan be performed using e ither fluoroscopic or ultrasound targeting fo r initial ent~ into the gallbladder (Figure 1 ). Mayo Clinic intervenrional radiologists have successfully placed catheters in 130 consecutive patients regardless of gallbladder anatomy, extent of hepatic attachment or gallbla<l<ler wall thickness. Discomfort has been managed using local anesthesia and intravenous fcntanyl and diazepam. Anticholinergic pre-me<licat 10n decrease:. the risk of vasovagal bradycardia and hypotension. When gallbladder capacity permits, one or two loops of the pigiail catheter (Cook Inc, Bloomington, Indiana) are placed in t he gallbladder with the pigtail preferably in the fundus. This min-1m1zes the potent1al for migration of the catheter out of the gallbladder. The small <l iameter catheter and transhepatic tract allow removal of the catheter ns soon ,ls stone dissolutton is complete, providing there is not extravasation at the gallbladder wall entry Stte when the gallbladder and ducts are filled with contrast. The potential for bile leakage after catheter removal <..an be minimized by leaving the catheter in place for several <lays, and this is prudent if substantial extravasation is apparent or 1f little or no gallbladder attachment to the liver is present. Gelfoam (UpJohn, Michigan) may be CAN J GASTROENTEROL VOL 4 No 9 DECEMBER 1990 Gallstone dissolution of the catheter. lnfuswn holes tire located only 111 the pigtail segmem. Left Com/>lete d1ssol11 uon of the swnes and a flatcm, stone-free dU(t system are dcmmtStrcHd before remm•al of the catheter Ultra.11mogmph'i the follou'lllg mom· mg rcwaled n11 resid11al 1wm: material placed in the rramhepat 1c track 10 decrease the risk ofhile leak via this route.
NASOB1LIARY CATHETER
PLACEMENT Endoscopic retrograde cathetenzation of the cystic duct can be achieved 10 most patients. The present authors and mhers have placed nasobiliary catheters into the gallbladJer for gallstone <lissolunon 10 a small number of patients but experience, especially in patients without dilated cysnc ducts, ts insufficient to predict an incidence of success (4, 5) . Stone d1ssolut1on by nasobil1ary catheter pre~ents potential advantages and disadvantages compared with the percutaneous approach. For example, patient tolerance of cathetcnzacion of the cystic duct, and case of creation of srnring in the gallbladder and of aspiration of insoluble debris through a long small diameter catheter need to be determined. Anatomic anomalies m the gallbh1dder will be more difficult to Jeal with at long distance.
Some patients prefer percutaneous placement to swallowing an endoscope and havmg a nasobiliary catheter in place. Nevertheless, endoscopic retrograde catheter placement deserves careful evaluation and perhap1:> randomized comparison with the well toleraied, sate and effective percuranem1s method.
GALLSTONE DISSOLUTION
Once the gallbladJer catheter is in pos1uon, as many stnncs a1:> possible arc corralled w11hm the circumference of the pigtail where srimng and con~equently dissolution b most effective. The volume of radiopaque contrast material which envelopes the ~cones bur does not extravasate at the catheter entry sit or overflow into the cystic duCL is determined. The volume of MTBE to be continuously infused and aspirated is that volume which will surround the stones but b several millilitres less than overflow volume. As long as this volume is greater than the dead space in the catheter, rapid dissolution can be achieved, often u1:,111g only 2or 3 mlofMTBE. lndeed, a small volume rapidly infused an<l aspirated induces more rapid dissolution than a large volume. Initial experience has been with a manual syringe lechnique during which the gallbladder is completely evacuated of a ll MTBE, bile and scone debris with each aspiration four to six times a minute.To avoid saturation with cholesterol, the treatment volume is equilibrated with 10 co 15 mL of MTBE in the syringe with each aspiration, and this re1:>ervoir volume is exchanged for fresh MTBE every 5 to 15 mins. The authors have recencly initiated testing of an automatic pump system developed jointly with Baxter Healthcare (Irvine, California) (6,7). This compressed air driven sy~tcm 626 produces rapid stirring which in vitro more than doubles the speed of stone dissolution compared co a manual method. M ulticcncre trials of this pump system are expected to begin in the United States and other counmes in 1990.
PATIENT SELECTION
Only patients wtth specific biliary stone symptoms should be considered for therapeutic intervention, except under unusual circumstances. If cystic or common bile duct stones are present, treatment may he successful, but dissolution or extraction of duct stones adds to the difficulty and length of the procedure. Success is nor as predictable as with stones in the gallbladder only. If cystic duct obstruction because of fibrosis is present, the patient will be left with hydrops and the potential for empyema in the future. Methods for ablating the gallbladder have not yet been shown to be safe and effective (8) .
Cholesterol stones radiolucent on computed romography scan will dissolve within one to three days leaving no or very minimal residual debri:; with rare exceptions (2) . Based on in vitro data, many stones which are radiolucent by abdominal plain film but cont a in mg diffuse or rim calcium demonstrable by computed tomography scan may be dissolved with MTBE using the automatic pump system (9) . Scones with more extensive calcification may be more efficiently treated nonsurgical-1 y by predissolution fragmentation using ex tracorporea I shock wave lithotnpsy (10) . If stones are radiolucent on computed tomography scan, however, solitary scones as large as 4 cm can be completely dissolved within 2 or 3 h without fragmentation. Indeed, fragmentation might scatter debris throughout the gallbladder or even the cystic duct, whereas a solitary stone will remam within the pigtail zone until completely dissolved.
The presence of irreversible coagulopathy, hepatic abscess or hemangioma in the potential transhepatic catheter path are contraindications to this procedure. Patients with acute cholecystitis who have a substantially incrca~cd ri~k for surgery can have catheter cholecystostomy performed and then dissolution therapy after resolution of the acuce inflammation. The most ideal candidates for MTBE treat• ment are patients with increased risk for surgery and with cholesterol stones having little or no calcium apparent on computed tomography scan. A variety of other patients may also be candidates for this treatment if nonsurgical rhcrapy is preferred. Cholesterol stones retained in the duct system can be dissolvl'd rapidly with MTBE but addmonal methods for retention and retrieval cJ MTBE mu1:,t be incorporated.
RESULTS
T reatmcnt with MTBE has been well tolerated in 130 consecutive patients including twowithduct,tones, three with cholecystostomies, and eight treated with sequential extracorporeal shock wave I ithotripsy followed by MTBE fragment dissolution. In four patients, having one, two, three and 14 stones, respectively, all less than or equal to 5 mm in diameter, although stone calcification was not apparent by computed tomography scan, the Mones were insoluble in MTBE. All of the other patients with little or no calcification apparent on computed tomography scan have had either no residue debris or small amounts of residue 5 mm or less in diameter. Only five patients have had debris apparent fluoroscop1· cally but most of the ochers have had one or more t1 ny echogenic densities with or withm1t acoustic shadowing detectable by ultrasonogram. This slight residue has not caused duc1 obstruction, pancreatitis or cholecystitis. Solitary stones up to 6 cm in 1m1ximum diameter have usually been completely dissolved within one or two days, but multiple large mixed cholesterol-pigment scone& usually require two to four days of treatmenrusmg the manual method. The SF catheter is very well tolerated in almost all patients and is connected to sterile bile bag dra111age overnight.
SIDE EFFECTS
Both catheter placement and MTBE treatment have been well tolerated. When pain has occurred from extra-vasation of hilc or MTBE, it has been treated with bupivacainc (Marcaine) infusion along the catheter entry tract and intravenous butorphannl (Sradol). By using small volumes of MTBE, the authors have never had to discontinue the procedure because of discomfort, and afrerthe first morning of treatment, most patients do not require further analgesia. Nausea and emes1s have been infrequent and transient, and have responded well to prochlorpcrazinc. Although MTBE 1s liquid at body temperature, it is moderately volatile anJ flammable and must he handled accordingly. Reasonable precautions to avoid spillage of substantial volumes and proper disposal procedures will minimize any hazard.
OVERVIEW
As experience and technLilogy evolve, most patients' srones sh(ltild be C(ltnpletely dissolved within one or rwo days with MTBE with minimal morbidity anJ almost immediate return LO work. This methodology should heappltcahlc to other solvents for choles tc ro l and nonchnlesrerLll srone Clllnpo11enns which may alsn he found to he safe and effective. Rapid dissolution of scone trngrnems usmg MTBE after extracorporcal lithotnpsy would avoid complicatinns from fragment passage and provide much more rapid and complere stone clearance than oral bi le acid dissolution therapy.
The cost of matenals and equ ipment for MTBE treatment is low, but the Gallstone dissolution procedure usually requires at least 2 h from hnth an 111terve11t1nnal rndiolog1st ,md gastroenrerologist as well as ahnut 6 h a day of a paramedical assistant's time. The .iuromanc pump system, however, should sho1 ten dissolution time and a llow two or three paucnls to be supervised by one paramedical assistant. As this and other nonsurgical or minor surgical alternatives to stand,ml chc)lecy:-.tecwrny evolvl', their cost and ult11m1te outcome musr be a~sesscd .md compared. The Jevelopmcnt of effective, safe and economical methlllls for prevention (lt stone recurrence will considerably expand the population of patients for whom nonsurgkal treatments will he 1he therapy of chrnce.
